Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Behzad Behnam, Mohammad Rezazadehkermani, Saeid Ahmadzadeh, Ahad mokhtarzadeh, Seyed Noureddin Nematollahi-Mahani & Abbas Pardakhty. (2018) Microniosomes for concurrent doxorubicin and iron oxide nanoparticles loading; preparation, characterization and cytotoxicity studies. Artificial Cells, Nanomedicine, and Biotechnology 46:1, pages 118-125.
Read now
Read now
Alberta Cappelli, Cinzia Pettinato & Rita Golfieri. (2014) Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments. Journal of Hepatocellular Carcinoma 1, pages 163-182.
Read now
Read now
Ruben Hernandez-Alcoceba, Bruno Sangro, Pedro Berraondo, Gloria Gonzalez-Aseguinolaza & Jesus Prieto. (2013) Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives. Expert Opinion on Investigational Drugs 22:7, pages 827-841.
Read now
Read now
Articles from other publishers (25)
Kelley Coffman-D’Annibale, Changqing Xie, Donna M Hrones, Shadin Ghabra, Tim F Greten & Cecilia Monge. (2023) The current landscape of therapies for hepatocellular carcinoma. Carcinogenesis 44:7, pages 537-548.
Crossref
Crossref
David Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, Ya Ruth Huo, Hao Xiang, Michael Vinchill Chan, Alice Unah Lee, Cynthuja Thailakanathan, Hazem Jebeili, Christopher Rogan, Ahmed Al‐Omary, Sidhartha Gupta, Ian Lockart, Neha Tiwari, McCawley Clark‐Dickson, James William Hillhouse, Robyn Laube, Jeff Chang, Vi Nguyen, Mark Danta, Robert Cheng, Simone Irene Strasser, Amany Zekry, Miriam Tania Levy, Christine Chan & Ken Liu. (2022) Selective internal radiation therapy for hepatocellular carcinoma: A 15‐year multicenter Australian cohort study. Journal of Gastroenterology and Hepatology 37:11, pages 2173-2181.
Crossref
Crossref
K. L. Murashko & A. M. Yurkovskiy. (2021) Occlusion of the vein adjacent to colorectal cancer liver metastasis as a way to increase the radicality of percutaneous radiofrequency thermal ablation. Health and Ecology Issues:3, pages 57-63.
Crossref
Crossref
Theresa H. Wirtz, Sven H. Loosen, Max Schulze‐Hagen, Joao Gorgulho, Jennis Kandler, Markus Joerdens, Münevver Demir, Raphael Mohr, Philipp Bruners, Christiane Kuhl, Christian Trautwein, Marie‐Luise Berres, Frank Tacke, Tom Luedde & Christoph Roderburg. (2021) Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies. Clinical and Translational Science 14:5, pages 1853-1863.
Crossref
Crossref
Kelvin Hong, Olaguoke Akinwande, Lisa Bodei, Murthy RK. Chamarthy, Phillip M. Devlin, Shana Elman, Suvranu Ganguli, Andrew S. Kennedy, Sonya J. Koo, Zoubir Ouhib, Siddharth A. Padia, Riad Salem, Reed G. Selwyn, Catheryn M. Yashar, Don C. Yoo, Bassem I. Zaki, Alan C. Hartford & Clayton K. Trimmer. (2021) ACR–ABS–ACNM–ASTRO–SIR–SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies. Brachytherapy 20:3, pages 497-511.
Crossref
Crossref
Sven H Loosen, Max Schulze‐Hagen, Mihael Vucur, Joao Gorgulho, Pia Paffenholz, Fabian Benz, Raphael Mohr, Münevver Demir, Alexander Wree, Christiane Kuhl, Christian Trautwein, Frank Tacke, Philipp Bruners, Tom Luedde & Christoph Roderburg. (2021) Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis. JGH Open 5:3, pages 356-363.
Crossref
Crossref
Lian Li, Bo Li & Ming Zhang. (2019) Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis. Acta Radiologica 61:6, pages 723-731.
Crossref
Crossref
David Prince, Ken Liu, Weiqi Xu, Minjiang Chen, Jin-Yu Sun, Xiao-Jie Lu & Jiansong Ji. (2020) Management of patients with intermediate stage hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 12, pages 175883592097084.
Crossref
Crossref
Андрей Бушманов, Andrey Bushmanov, О. Клементьева, O. Klement'eva, А. Лабушкина, A. Labushkina, А. Тултаев, A. Tultaev, В. Корсунский, V. Korsunskiy, О. Кузнецова & O. Kuznetsova. (2019) Actual Problems and Perspectives of the Application of Nuclear Medicine Techniques in the Diagnostic and Treatment of Hepatocellular Carcinoma: Analytical Review. Medical Radiology and radiation safety 64:5, pages 58-68.
Crossref
Crossref
X. Zhang, J. Zhou, D.-D. Zhu, J. Huang, J.-H. Sun, T.-F. Li, C.-S. Shi, Z.-C. Sun, Q.-M. Hou, Z.-Y. Peng, W.-Q. Yu, J.-S. Ji, W.-J. Gu, G.-H. Zhou, X.-X Xie, X.-H. Guo, G.-H. Cao, Z.-H. Yu, H.-H. Xu, J. Fang, S.-H. Ying, W.-H. Hu, W.-B. Ji, J. Han, X. Wu, J.-P. Zheng, J. Luo, Y.-T. Chen, T.-Y. Hu, L. Li, H.-J. Hu, H.-J. Du & G.-L. Shao. (2018) CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study. Clinical and Translational Oncology 21:2, pages 167-177.
Crossref
Crossref
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher & Valérie Vilgrain. (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 69:1, pages 182-236.
Crossref
Crossref
Delia D'Avola, Verónica Fernández-Ruiz, Francisco Carmona-Torre, Miriam Méndez, Javier Pérez-Calvo, Felipe Prósper, Enrique Andreu, José Ignacio Herrero, Mercedes Iñarrairaegui, Carmen Fuertes, José Ignacio Bilbao, Bruno Sangro, Jesús Prieto & Jorge Quiroga. (2017) Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells. Translational Research 188, pages 80-91.e2.
Crossref
Crossref
Jae Seung Lym, Quang Vinh Nguyen, Da Woon Ahn, Cong Truc Huynh, Hwan Jun Jae, Young Il Kim & Doo Sung Lee. (2016) Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy. Acta Biomaterialia 41, pages 253-263.
Crossref
Crossref
Kang Mo Kim. (2015) Nonsurgical multidisciplinary approach for recurrent hepatocellular carcinoma after surgical resection. Hepatic Oncology 2:1, pages 29-38.
Crossref
Crossref
Eleonora Terzi, Fabio Piscaglia, Ludovica Forlani, Cristina Mosconi, Matteo Renzulli, Luigi Bolondi & Rita Golfieri. (2014) TACE performed in patients with a single nodule of Hepatocellular Carcinoma. BMC Cancer 14:1.
Crossref
Crossref
Adam D. Talenfeld, Akhilesh K. Sista & David C. Madoff. (2014) Transarterial Therapies for Primary Liver Tumors. Surgical Oncology Clinics of North America 23:2, pages 323-351.
Crossref
Crossref
Suhrid Lodh, Richard Maher & Alexander Guminski. (2014) Intra-arterial infusion and chemo-embolization for melanoma liver metastases. Journal of Surgical Oncology 109:4, pages 376-382.
Crossref
Crossref
Eleonora Terzi, Laura Terenzi, Laura Venerandi, Luca Croci, Matteo Renzulli, Cristina Mosconi, Giulia Allegretti, Alessandro Granito, Rita Golfieri, Luigi Bolondi & Fabio Piscaglia. (2014) The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. Digestive Diseases 32:6, pages 711-716.
Crossref
Crossref
Jens M. Theysohn, Stefan Müller, Jörg F. Schlaak, Judith Ertle, Thomas W. Schlosser, Andreas Bockisch & Thomas C. Lauenstein. (2012) Selective Internal Radiotherapy (SIRT) of Hepatic Tumors: How to Deal with the Cystic Artery. CardioVascular and Interventional Radiology 36:4, pages 1015-1022.
Crossref
Crossref
Osama M. Hetta, Waleed M. Hetta, Naglaa H. Shebrya & Hesham A. El Ghazaly. (2013) Radioembolization with Yttrium-90 resin microspheres in treatment of HCC with or without PVT: Initial Egyptian experience. The Egyptian Journal of Radiology and Nuclear Medicine 44:2, pages 215-222.
Crossref
Crossref
Argyro Mazioti, Nikolaos K. Gatselis, Christos Rountas, Kalliopi Zachou, Dimitrios K. Filippiadis, Kostantinos Tepetes, George K. Koukoulis, Ioannis Fezoulidis & George N. Dalekos. (2013) Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma. Hepatitis Monthly 13:5.
Crossref
Crossref
E. Terzi, R. Golfieri, F. Piscaglia, M. Galassi, A. Dazzi, S. Leoni, E. Giampalma, M. Renzulli & L. Bolondi. (2012) Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”. Journal of Hepatology 57:6, pages 1258-1267.
Crossref
Crossref
Bruno Sangro, Mercedes Iñarrairaegui & Jose I. Bilbao. (2012) Radioembolization for hepatocellular carcinoma. Journal of Hepatology 56:2, pages 464-473.
Crossref
Crossref
Daniel Shouval. (2011) Focus. Journal of Hepatology 55:6, pages 1169-1170.
Crossref
Crossref
Bruno Sangro, Livio Carpanese, Roberto Cianni, Rita Golfieri, Daniele Gasparini, Samer Ezziddin, Philipp M. Paprottka, Francesco Fiore, Mark Van Buskirk, Jose Ignacio Bilbao, Giuseppe Maria Ettorre, Rita Salvatori, Emanuela Giampalma, Onelio Geatti, Kai Wilhelm, Ralf Thorsten Hoffmann, Francesco Izzo, Mercedes Iñarrairaegui, Carlo Ludovico Maini, Carlo Urigo, Alberta Cappelli, Alessandro Vit, Hojjat Ahmadzadehfar, Tobias Franz Jakobs & Secondo Lastoria. (2011) Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation. Hepatology 54:3, pages 868-878.
Crossref
Crossref